Just Out📣at 📰Review finds presence of sarcopenia & systemic inflammation decreased📉PFS & OS in cohort of9️⃣0️⃣pts who got #immunotherapy 🦠in phase1️⃣clinical trials. This could possibly aid in risk stratifying pts👩‍🦳👱‍♂️ starting immunotherapy⚠️
Is there a role for "inflammageing" and sarcopenia as a predictor of mortality in #immunotherapy treatment? Or is this simply a surrogate for "frailty" of patients in general? Interesting stuff.... #gerionc